Home > GOAL Trial Shows Penicillin Significantly Reduces the Progression of Latent RHD in Ugandan Children
GOAL Trial Shows Penicillin Significantly Reduces the Progression of Latent RHD in Ugandan Children
18 Nov 2021 - 13:45
Findings of a clinical trial published in the New England Journal of Medicine on 13 November 2021 shed new light on the efficacy of secondary antibiotic prophylactic pencillin in preventing the progression of latent rheumatic heart disease in children and adolescents. Authors found that patients who received prophylactic penicillin were significantly less likely to experience disease progression compared to those who did not receive treatment - an important finding for future treatment recommendations and further research.
Take a look at these press releases and blog posts to find out more about the trial and next steps: